Are biologics effective on lung hyperinflation in patients with resistant asthma? - 20/05/24
Doi : 10.1016/j.rmed.2024.107652
Toshiro Goto ⁎ 
, Christian Gomez Hernandez
, Christian Gomez Hernandez Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, 281 First Avenue, New York, NY, 10003, USA
⁎Corresponding author.
Yasushi Tsujimoto
Oku Medical Clinic, Shimmori 7-1-4, Asahi-ku, Osaka, 535-0022, Japan
Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine, School of Public Health, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan
Scientific Research WorkS Peer Support Group (SRWS-PSG), Osaka, Japan
Takashi Kitagawa
Department of Physical Therapy, School of Health Sciences, Shinshu University 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan
Scientific Research WorkS Peer Support Group (SRWS-PSG), Osaka, Japan
Le texte complet de cet article est disponible en PDF.
Plan
© 2024
Elsevier Ltd. Tous droits réservés.
Vol 227
Article 107652- juin 2024 Retour au numéro
Article précédent
- Sarcoid-like reactions to immune checkpoint inhibitors: Incidence, treatment course, and impact on cancer progression and survival
- Hannah Smith, Robert Easterling, Jianing Ma, Meghana Moodabagil, Alexa Meara, Dwight H. Owen, Elliot Crouser, Arindam Singha, Kevin Ho
- Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply
- Mario Cazzola, Mauro Maniscalco
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?